NCT05354752View on ClinicalTrials.gov

Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 18, 2022

Primary Completion Date

November 2, 2022

Study Completion Date

November 15, 2022

Conditions
Inflammatory Bowel Diseases
Interventions
DRUG

VC005 tablets

VC005 groups repeat administration for 7 days

DRUG

VC005 Placebo tablets

VC005 placebo groups repeat administration for 7 days

Trial Locations (1)

130000

The First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Jiangsu vcare pharmaceutical technology co., LTD

INDUSTRY